Fate Therapeutics, Inc. · NASDAQ:FATE
Tahl Cindy exercised options for 166,664 Fate Therapeutics, Inc. shares (Form 4)
Traded May 6, 2026 · Filed May 7, 2026
On May 6, 2026, Tahl Cindy (See Remarks) exercised options for 166,664 Fate Therapeutics, Inc. shares at an average US$1.25 for US$208K, leaving 653,745 shares. Filed May 7, 2026 (Form 4).
- Options exercised
- 166,664 shares
- Price
- US$1.25 average (US$1.05 to US$1.32)
- Value
- US$208K
- Holding after
- 653,745 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 6, 2026 | Common Stock | Option exercise | 122,220 | US$1.32 | 609,301 | Direct |
| May 6, 2026 | Common Stock | Option exercise | 44,444 | US$1.05 | 653,745 | Direct |
Source
Related
- Fate Therapeutics, Inc.
- Tahl Cindy
- Fate Therapeutics, Inc. shareholders
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Valamehr Bahram · May 21, 2026
- Form 4 · Epstein Robert S · May 6, 2026
- Form 4 · Rastetter William H · May 6, 2026